More on TMCI
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.44 |
|
|||
| Open | $4.42 | ||||
| 52 Wk High | $3.25 | ||||
| 52 Wk Low | $0.65 | ||||
| Day High | $4.44 | ||||
| Day Low | $4.26 | ||||
| P/E | N/A | ||||
| EPS | $-0.06 | ||||
| Volume | 90,331 | ||||
- Treace reports 5-year Lapiplasty study data at AOFAS meeting
- Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
- Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting
- Form 4 TREACE MEDICAL CONCEPTS, For: Aug 20 Filed by: Treace John T.
- Form SCHEDULE 13G/A TREACE MEDICAL CONCEPTS, Filed by: ARMISTICE CAPITAL, LLC
- Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Scanlan Sean F.
- Form SCHEDULE 13G/A TREACE MEDICAL CONCEPTS, Filed by: Treace John T.
- Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Hair Mark
- Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Elder Scot Michael
- Treace Medical Concepts Inc (TMCI) PT Raised to $5 at Truist Securities
Entities mentioned with TMCI
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Twitter | View Related Stories »
- IPO | View Related Stories »
- 13G | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
